Davide Moi

2.8k total citations · 2 hit papers
23 papers, 1.9k citations indexed

About

Davide Moi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Davide Moi has authored 23 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Davide Moi's work include Immunotherapy and Immune Responses (5 papers), Immune cells in cancer (5 papers) and Immune Cell Function and Interaction (4 papers). Davide Moi is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Immune cells in cancer (5 papers) and Immune Cell Function and Interaction (4 papers). Davide Moi collaborates with scholars based in Australia, Italy and United States. Davide Moi's co-authors include Luigi Naldini, Roberta Mazzieri, Michele De Palma, Ferdinando Pucci, Bernhard Gentner, Anna Ranghetti, Erika Zonari, Letterio S. Politi, Mary Anna Venneri and Alvise Berti and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Blood.

In The Last Decade

Davide Moi

23 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells

2011 489 citations Roberta Mazzieri, Ferdinando Pucci et al. Cancer Cell profile →
Targeted genome editing in human repopulating haematopoietic stem cells

2014 434 citations Pietro Genovese, Giulia Schiroli et al. Nature profile →

Peers

Countries citing papers authored by Davide Moi

Since Specialization

Citations

This map shows the geographic impact of Davide Moi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Moi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Moi more than expected).

Fields of papers citing papers by Davide Moi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Moi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Moi. The network helps show where Davide Moi may publish in the future.

Co-authorship network of co-authors of Davide Moi

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Moi. A scholar is included among the top collaborators of Davide Moi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Moi. Davide Moi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 3763: Comparative spatial analyses of the tumor immune landscape in different mouse models of glioblastoma 2024 ·Cancer Research ·(unknown), Niyati Jhaveri, Aditya Pratapa, (unknown), (unknown), (unknown), Riccardo Dolcetti, Davide Moi, Roberta Mazzieri, Theo Mantamadiotis	1
2	CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers 2024 ·Oncogene ·Prahlad V. Raninga, Bijun Zeng, Davide Moi, (unknown), Federica Saletta, (unknown), Chelsea Mayoh, Rochelle C. J. D’Souza, Bryan W. Day, (unknown), Orazio Vittorio, Roberta Mazzieri, Riccardo Dolcetti, Kum Kum Khanna	2
3	Abstract B001: Intra- and inter-tumoral heterogeneity of melanoma across different metastatic sites 2024 ·Cancer Research ·(unknown), Reem Saleh, Benjamin J. Blyth, Xin Du, Dane Vassiliadis, Katie Fennell, Davide Moi, Roberta Mazzieri, Riccardo Dolcetti, Karen E. Sheppard, Grant A. McArthur	1
4	Skin-Grafting and Dendritic Cell “Boosted” Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines 2023 ·Cells ·Bijun Zeng, Davide Moi, (unknown), (unknown), Ian H. Frazer, Christopher Perry, Riccardo Dolcetti, Roberta Mazzieri, Jazmina L. Gonzalez Cruz	1
5	Multiparametric flow cytometry to characterize vaccine-induced polyfunctional T cell responses and T cell/NK cell exhaustion and memory phenotypes in mouse immuno-oncology models 2023 ·Frontiers in Immunology ·Davide Moi, Bijun Zeng, Simone A. Minnie, (unknown), (unknown), David P. Sester, Roberta Mazzieri, Riccardo Dolcetti	3
6	A novel add‐on collimator for preclinical radiotherapy applications using a standard cell irradiator: design, construction, and validation 2020 ·Medical Physics ·Davide Fontanarosa, Jessica Benitez Mendieta, (unknown), Andrew Fielding, (unknown), Jamie Trapp, Davide Moi, (unknown), Marco Petasecca, Roberta Mazzieri	5
7	Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy 2018 ·Journal of Clinical Investigation ·Bijun Zeng, Anton P. J. Middelberg, (unknown), Kelli P. A. MacDonald, Alan G. Baxter, Meghna Talekar, Davide Moi, Kirsteen M. Tullett, Irina Caminschi, Mireille H. Lahoud, Roberta Mazzieri, Riccardo Dolcetti, Ranjeny Thomas	74
8	Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma 2018 ·Biomaterials ·Ferdinand Wagner, Boris Michael Holzapfel, Jacqui McGovern, Abbas Shafiee, Jeremy Baldwin, (unknown), Christoph A. Lahr, Felix M. Wunner, Thor Friis, Onur Bas, Melanie Boxberg, Peter Michael Prodinger, Ali Shokoohmand, Davide Moi, Roberta Mazzieri, Daniela Loessner, Dietmar W. Hutmacher	36
9	Immune system augmentation via humanization using stem/progenitor cells and bioengineering in a breast cancer model study 2018 ·International Journal of Cancer ·Abbas Shafiee, Jacqui McGovern, Christoph A. Lahr, Christoph Meinert, Davide Moi, Ferdinand Wagner, Marietta Landgraf, Elena M. De‐Juan‐Pardo, Roberta Mazzieri, Dietmar W. Hutmacher	28
10	Adoptive transfer of genetically engineered monocytes for the tumour targeted delivery of IFN-alpha 2018 ·Cytotherapy ·Davide Moi, Emily Wilson, (unknown), Sabina Chiaretti, Roberta Mazzieri	2
11	B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity 2017 ·OncoImmunology ·(unknown), Zewen Kelvin Tuong, T Kobayashi, (unknown), Megan S. F. Soon, Michael Nissen, Pui Yeng Lam, Colm Keane, Frank Vari, Davide Moi, Roberta Mazzieri, Graham R. Leggatt, Maher K. Gandhi, Stephen R. Mattarollo	15
12	Interleukin‐23 regulates interleukin‐17 expression in wounds, and its inhibition accelerates diabetic wound healing through the alteration of macrophage polarization 2017 ·The FASEB Journal ·James Lee, Mathieu P. Rodero, Jatin Patel, Davide Moi, Roberta Mazzieri, Kiarash Khosrotehrani	57
13	Angiopoietin 2 expression in the cornea and its control of corneal neovascularisation 2016 ·British Journal of Ophthalmology ·Giulio Ferrari, Chiara Giacomini, Fabio Bignami, Davide Moi, Anna Ranghetti, Claudio Doglioni, Luigi Naldini, Paolo Rama, Roberta Mazzieri	10
14	Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1 2015 ·Cancer Research ·Roberta Mazzieri, Giovanni Pietrogrande, (unknown), Alessandro Gandelli, Piergiuseppe Colombo, Davide Moi, Chiara Brombin, Alessandro Ambrosi, Silvio Danese, Paolo Mignatti, Francesco Blasi, Silvia D’Alessio	10
15	Targeted genome editing in human repopulating haematopoietic stem cells breakdown → 2014 ·Nature ·Pietro Genovese, Giulia Schiroli, Giulia Escobar, Tiziano Di Tomaso, Claudia Firrito, Andrea Calabria, Davide Moi, Roberta Mazzieri, Chiara Bonini, Michael C. Holmes, Philip D. Gregory, Mirjam van der Burg, Bernhard Gentner, Eugenio Montini, Angelo Lombardo, Luigi Naldini	434
16	Genetic Engineering of Hematopoiesis for Targeted IFN-α Delivery Inhibits Breast Cancer Progression 2014 ·Science Translational Medicine ·Giulia Escobar, Davide Moi, Anna Ranghetti, (unknown), Mario Leonardo Squadrito, Anna Kajaste‐Rudnitski, Attilio Bondanza, Bernhard Gentner, Michele De Palma, Roberta Mazzieri, Luigi Naldini	94
17	miR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages 2012 ·Cell Reports ·Mario Leonardo Squadrito, Ferdinando Pucci, Laura Magri, Davide Moi, Gregor D. Gilfillan, Anna Ranghetti, Andrea Casazza, Massimiliano Mazzone, Robert Lyle, Luigi Naldini, Michele De Palma	167
18	Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells breakdown → 2011 ·Cancer Cell ·Roberta Mazzieri, Ferdinando Pucci, Davide Moi, Erika Zonari, Anna Ranghetti, Alvise Berti, Letterio S. Politi, Bernhard Gentner, Jeffrey L. Brown, Luigi Naldini, Michele De Palma	489
19	Tumor-Targeted Interferon-α Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis 2008 ·Cancer Cell ·Michele De Palma, Roberta Mazzieri, Letterio S. Politi, Ferdinando Pucci, Erika Zonari, Giovanni Sitia, Stefania Mazzoleni, Davide Moi, Mary Anna Venneri, Stefano Indraccolo, Andrea Falini, Luca G. Guidotti, Rossella Galli, Luigi Naldini	235
20	In vitro differentiation of human monocytes to macrophages results in depletion of antioxidants and increase in n‐3 fatty acids levels 2000 ·FEBS Letters ·Francesco Visioli, Franca Marangoni, Davide Moi, Patrizia Risé, Cláudio Galli	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact